Adults with chronic Trypanosoma cruzi exhibit a poorly functional T cell compartment, characterized by monofunctional (IFN-γ-only secreting) parasite-specific T cells and increased levels of terminally differentiated T cells. It is possible that persistent infection and/or sustained exposure to parasites antigens may lead to a progressive loss of function of the immune T cells.
To test this hypothesis, the quality and magnitude of T. cruzi-specific T cell responses were evaluated in T. cruzi-infected children and compared with long-term T. cruzi-infected adults with no evidence of heart failure. The phenotype of CD4+ T cells was also assessed in T. cruzi-infected children and uninfected controls. Simultaneous secretion of IFN-γ and IL-2 measured by ELISPOT assays in response to T. cruzi antigens was prevalent among T. cruzi-infected children. Flow cytometric analysis of co-expression profiles of CD4+ T cells with the ability to produce IFN-γ, TNF-α, or to express the co-stimulatory molecule CD154 in response to T. cruzi showed polyfunctional T cell responses in most T. cruzi-infected children. Monofunctional T cell responses and an absence of CD4+TNF-α+-secreting T cells were observed in T. cruzi-infected adults. A relatively high degree of activation and differentiation of CD4+ T cells was evident in T. cruzi-infected children.
Our observations are compatible with our initial hypothesis that persistent T. cruzi infection promotes eventual exhaustion of immune system, which might contribute to disease progression in long-term infected subjects.
Chagas disease is a neglected tropical disease affecting approximately 10 million people in the world. As a consequence of migration flows, the disease has also become established in non-endemic countries. Previous studies have demonstrated that Trypanosoma cruzi-specific T cells inversely correlates with the severity of cardiac disease in the chronic phase of the infection, suggesting that the immune system becomes exhausted overtime. To test this hypothesis, the quality and magnitude of T. cruzi-specific T cell responses were measured in T. cruzi-infected children – who are presumed to have shorter-term infections - and compared with long-term T. cruzi-infected adults. The activation status of total T cells in T. cruzi-infected children was also evaluated. T. cruzi-infected children exhibit a more robust, and more highly functional parasite specific T cell responses compared to T. cruzi-infected adults. In spite of a more functional immune profile, T. cruzi-infected children have a heightened state of immune activation. These observations are compatible with the initial hypothesis that T cell responses specific for T. cruzi become exhausted overtime. The impairment in T cell responses might contribute to disease progression in long-term infected subjects.
Citation: Albareda MC, De Rissio AM, Tomas G, Serjan A, Alvarez MG, et al. (2013) Polyfunctional T Cell Responses in Children in Early Stages of Chronic Trypanosoma cruzi Infection Contrast with Monofunctional Responses of Long-term Infected Adults. PLoS Negl Trop Dis 7(12): e2575. doi:10.1371/journal.pntd.0002575
Editor: Eric Dumonteil, Universidad Autónoma de Yucatán, Mexico
Received: July 7, 2013; Accepted: October 22, 2013; Published: December 12, 2013
Copyright: © 2013 Albareda et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by The National Institutes of Health [grant R01AI0833188 to SAL]; Ministerio de Salud de la Provincia de Buenos Aires; Ministerio de Salud de la Nación, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Chagas disease, a neglected tropical disease affecting approximately 10 million people from south of the United States to Mexico and Central and South America , is caused by the protozoan parasite Trypanosoma cruzi. As a consequence of migration flows, the disease has been also become established in non-endemic countries .
T. cruzi frequently results in the development of cardiomyopathy, generally many years after the initial infection. Three factors are likely associated with the development of severe disease: parasite burden; the effectiveness of the host immune response in controlling parasites in specific tissues, and the effectiveness of the host immune response in limiting peripheral damage , . Chronic infections in general are associated with a progressive loss of pathogen-specific T cell function known as immune exhaustion , . We have previously shown that adults with chronic T. cruzi-infections exhibit a prevailing profile of parasite-specific Interferon (IFN)-γ only secreting T cells , associated with long-term antigen persistence and exhausted T cells . The frequencies of T. cruzi-specific T cells were also found to inversely correlate with the severity of chronic Chagas disease , .
Although, T. cruzi-infected children are likely to have shorter-term infections than most adults, the overall CD8 T cell compartment in children in the early phase of chronic T. cruzi infection exhibits decreased levels of naïve T cells and increased levels of terminally differentiated antigen-experienced T cells . Other studies have suggested that T. cruzi-infected children have a mixed T cell profile with the production of IFN-γ and IL-4 , . However, a comprehensive analysis of the ability of T. cruzi specific T cells to co-express multiple functions has not been performed.
In order to examine the progression of immune exhaustion in chronic T. cruzi infection, we have assessed the quantitative and qualitative attributes of T. cruzi-specific T cell responses in early stages of Chagas disease in children in comparison to T. cruzi-infected adults. The degree of activation, differentiation and antigen exposure of total CD4+ T cells was also evaluated in T. cruzi-infected children. The primary finding is that T. cruzi-infected children have a higher frequency of polyfunctional and more robust T cell responses specific for T. cruzi compared to T. cruzi-infected adults, and a heightened state of immune activation of CD4+ T cells.
Materials and Methods
This protocol was approved by the Institutional Review Boards of the Hospital Interzonal General de Agudos Eva Perón, and the Centro Nacional de Genética, Buenos Aires, Argentina. Informed written consent was obtained from adult subjects and the parents of all children included in this study.
Five to 16-year old children and 29 to 63 year-old adults were enrolled at the Instituto Nacional de Parasitología Dr. Mario Fatala Chaben and at the Hospital Interzonal General de Agudos Eva Perón, (Buenos Aires, Argentina). T. cruzi infection was determined by indirect immunofluorescence, haemagglutination and ELISA assays . Subjects positive on at least two of these tests were considered to be infected. All infected children were in the early chronic phase of T. cruzi infection. Age- and sex-matched children with negative serological findings were recruited as uninfected controls. T. cruzi-infected subjects were classified according to a modified version of the Kuschnir grading system , . Most subjects were in the indeterminate phase of the infection (Group 0; positive serology and normal findings on electrocardiogaphy, chest radiography and echocardiography), while 3 subjects (2 adults and one child) belong to the Group 1 group (positive serology, abnormal findings on electrocardiography and normal chest radiography and echocardiography). All participants of this study had not received etiological treatment at the time of sampling and started drug therapy with benznidazole after sampling.
Children and adults with any impaired health condition such as severe nephropathy, liver disease, severe neuropathy, severe anaemia or homeopathy were excluded from the study. Data on the number, sex, age, clinical and epidemiologic features of the subjects included in this study are summarized in Table 1.
Collection of peripheral blood mononuclear cells (PBMC) and sera
Approximately 10 mL of blood were drawn by venipuncture into heparinized tubes (Vacutainer; BD Biosciences). PBMC were isolated by density gradient centrifugation on Ficoll-Hypaque (Amersham) and were cryopreserved for later analysis. Additional 2 mL of blood were allowed to coagulate at 37°C and centrifuged at 1000 g for 15 min for sera separation.
Protein lysate from T. cruzi amastigotes was obtained by freeze/thaw cycles followed by sonication as previously reported .Tetanol Pur (Novartis, Germany) was used as source of tetanus toxoid.
HLA-A01, A02, A03, A24 and B44-supertype binding epitopes encoded by the trans-sialidase gene family of T. cruzi and peptides derived from Influenza (Flu) virus with high binding-affinity for the common class I HLA-supertypes A01, A02 and A03 were synthesized at the University of Georgia Molecular Genetics Instrumentation Facility (Athens, USA).
IFN-γ and IL-2 enzyme-linked immunosorbent spot (ELISPOT) assays
The number of T. cruzi antigen-responsive IFN-γ- and IL-2-secreting T cells was determined by ex vivo ELISPOT using commercial kits (BD Biosciences), as described elsewhere , , . Cryopreserved PBMC were seeded in triplicate wells, at a concentration of 4×105 cells/well, and stimulated with T. cruzi lysate (10 µg/mL) or with peptide pools from the trans-sialidase protein family (7–13 peptides per pool, 5 µg/ml/peptide). For controls, PBMCs were incubated with either 20 ng/mL phorbol 12-myristate 13-acetate (PMA, Sigma) plus 500 ng/mL ionomycin (Sigma), Flu virus (3 peptides per pool, 5 µg/ml/peptide), tetanus toxoid (4 I.U./ml) or media alone (unstimulated control) for 16–20 hr at 37°C and 5% CO2. Spot forming cells (SFC) were automatically enumerated using ImmunoSpot analyzer (CTL). The mean number of spots in triplicate wells was obtained for each condition, and the number of specific IFN-γ and IL-2-secreting T cells was calculated by subtracting the value of the wells containing media alone from the antigen-stimulated spot count. Responses were considered significant if a minimum of 10 spots/4×105 PBMC were present per well, and additionally, this number was at least twice the value of wells with media alone .
Whole blood intracellular and surface staining assays
For polyfunctional analysis, 200 µL heparinized blood, half diluted in RPMI, were incubated with T. cruzi lysate in the presence of anti-CD28 and anti-CD49d antibodies (1 µg/ml; BD Pharmingen), for 16–20 h at 37°C. Ten µg/ml brefeldin A (Sigma) were added for the last 5 h of incubation, as previously described . Blood incubated with no antigen served as a negative control (unstimulated control), while blood incubated with Staphylococcal enterotoxin B (1 µg/ml; Sigma-Aldrich) served as a positive control. Twenty mM EDTA was added for 15 min. Cells were then stained with anti-human CD4-peridinin chlorophyll protein (PerCP) ensued by red cell lysis and white cell fixation in FACS Lysing Solution (Pharmingen). This was followed by fixation and permeabilization with Cytofix/Cytoperm solution (Pharmingen) according to manufacturer's instructions. Cells were stained with a combination of monoclonal antibodies specific for IFN-γ [phycoerythrin (PE)], tumor necrosis factor (TNF)-α [allophycocyanin (APC)] and CD154 (CD40L) [fluorescein isothiocyanate (FITC)], all from BD Bioscience. Since CD154 is only transiently expressed on the cell surface , intracellular expression of CD154 was measured, as previously described . In order to confirm that cytokine/co-stimulation expression was derived from T cells, anti-human CD3-FITC or CD3-PerCP was added in polyfunctional staining assays in combination with CD4, IFN-γ and TNF-α or CD4, IFN-γ and CD154, respectively.
Typically, 500,000 lymphocytes were acquired on a FACScalibur (Becton Dickinson Immunocytometry Systems) and analyzed using FlowJo software (TreeStar, Inc.) Lymphocytes were identified based on their scatter patterns and CD4 expression for the combination of IFN-γ, TNF-α and CD154; and based on scatter patterns as well as CD3 and CD4 expression for the combination of IFN-γ and TNF-α or IFN-γ and CD154. Boolean combination gating was then performed to calculate the frequencies of expression profiles corresponding to the seven different combinations of functions by using the FlowJo software. After subtracting the background values, the proportions of the different subsets were expressed as percentages of total cytokine or CD154-positive cells. Responses to the T. cruzi lysate were considered positive, for any particular subset, if the frequency of cytokine/CD154-positive T cells was threefold higher than the frequency in medium alone and above 0.07% of total CD4+ T cells, since the limit of detection was set at 0.01%.
Whole blood surface staining assays
For phenotypic analysis of total CD4+ T cells, 50 µL of whole blood were incubated with different combinations of CD4 (PerCP), CD45RA (FITC or APC), CD27 (PE), CD28 (PE), CD127 (PE), HLA-DR (FITC) and KLRG1 (APC) monoclonal antibodies (BD Biosciences), followed by red cell lysis and white cell fixation in FACS Lysing Solution (Pharmingen). Typically, 500,000 lymphocytes were acquired on the FACScalibur (Becton Dickinson Immunocytometry Systems) and analyzed using FlowJo software (TreeStar, Inc.)
Demographic and clinical characteristics of T. cruzi-infected subjects included in this study were summarized using range and median and compared with healthy participants using Kruskal-Wallis test with Dunn correction and Fisher's exact tests for numerical and categorical variables, respectively. Comparisons of the frequencies of responders in the different categories of ELISPOT responses among T. cruzi-infected children and between T. cruzi-infected children and the uninfected group were evaluated by use of the chi 2 test and Fisher's exact test. To compare the number of spots,as well as the magnitude of CD4+ T cells responses among triple, double or single functional profiles, the Kruskal-Wallis nonparametric analysis with Dunn correction was used. The percentages of responding CD4+ T cells for each cytokine within and among the children and adult groups were compared by the Kruskal-Wallis nonparametric analysis with Dunn correction and Mann-Whitney U test, respectively. T cell phenotypes in T. cruzi-infected children and uninfected controls were compared applying the Mann-Whitney U-test. Differences were considered to be statistically significant at P<0.05.
Clinical and demographic characteristics of study population
The main characteristics of the entire study population are summarized in Table 1. T. cruzi-infected and uninfected children enrolled in the study were all born from mothers with positive serology for T. cruzi infection and, at the time of the study all children were living in Buenos Aires, where T. cruzi infection is not endemic. T. cruzi-infected and uninfected groups of children included individuals born in areas endemic for T. cruzi infection and individuals born in non-endemic areas. Seropositive children who had not lived in endemic areas are presumed to have been infected congenitally. Only one child out of the fifty T. cruzi-infected children showed a right bundle branch block that is among the electrocardiographic alterations related to Chagas disease. Abnormal findings in the electrocardiography not related to Chagas disease, including sinusal tachycardia, incomplete right bundle branch block and premature atrial contraction , were more frequent among T. cruzi-infected children born in areas endemic for T. cruzi infection than those born in non-endemic areas (Table 1). The presence of these electrocardiographic alterations were not correlated with the age or gender of children. All T. cruzi-infected adults were born in areas endemic for T. cruzi infection but have lived in Buenos Aires for more than 15 years, in average. Two adult patients belonged to the G1 clinical stage of the Kuschnir classification , showing left anterior fascicular block while the remaining 8 subjects belong to the G0 group.
Frequencies of cytokine-producing cells specific for T. cruzi in children in early stages of Chagas disease
We have previously reported an inverse correlation between the frequency of IFN-γ-producing T cells responsive to T. cruzi antigens and disease severity in chronically infected adults , . In this study, the magnitude of T. cruzi-specific T cell responses was assessed in 17 T. cruzi-infected children by measuring the total frequency of IFN-γ- and IL-2-producing cells by ELISPOT assays after stimulation of PBMC with T. cruzi antigens. Since we had shown that in chronically T. cruzi-infected humans, the frequency of T cells specific for class-I-restricted T. cruzi epitopes (CD8+ epitopes) ,  or T. cruzi–derived recombinant proteins  is low to be consistently detected, an amastigote lysate preparation was the primary antigen stimulus for ELISPOT assays.
More than 75% of infected children had detectable cytokine responses to T. cruzi-antigens, with secretion of IFN-γ and IL-2 in nearly 60% of T. cruzi-infected children and, approximately 18% with IFN-γ-only responses. IL-2-only responses were not observed in T. cruzi-infected children (Table 2). None of the seronegative children born from mothers with positive serology for T. cruzi infection had positive ELISPOT responses (Table 2). The number of IFN-γ spots in subjects with concomitant IFN-γ and IL-2 positive ELISPOT responses was higher than the number of IFN-γ spots in IFN-γ-only responders (Figure 1A). Likewise, the former group showed higher spot counts for IFN-γ than IL-2
PBMC from T. cruzi-infected children were seeded at 4×105 cells/well and stimulated with a T. cruzi lysate from the Brazil strain, class-I-restricted HLA-A01, HLA-A02, HLA-A03, HLA-A24, HLA-B07 and HLA-B44 supertype trans-sialidase peptide pools, class-I-restricted Flu-derived peptides or media alone for 16–20 h. (A) T cell responses to a T. cruzi lysate preparation. Each circle represents the mean spot number of triplicate wells for each patient with positive ELISPOT responses out of seventeen assessed. Spot counts with media alone were subtracted. Vertical lines depicting median values are shown. IFN-γ-DP, no. of IFN-γ spots in individuals with positive responses for both IFN-γ and IL-2 ELISPOT assays; IFN-γ-SP, no. of IFN-γ spots in individuals with positive ELISPOT responses for IFN-γ alone; IL-2-DP, no. of IL-2 spots in individuals with positive responses for both IFN-γ and IL-2 ELISPOT assays; IL-2-SP, no. of IL-2 spots in individuals with positive ELISPOT responses for IL-2 alone. (*) P<0.01 vs. IL-2-DP; vs. IL-2-SP and vs. IFN-γ-SP by the Kruskal-Wallis test with Dunn correction. (B) Class I-restricted IFN- γ and IL-2 ELISPOT responses to trans-sialidase peptides. Representative positive ELISPOT responses for IFN-γ (grey bars) and IL-2 (white bars) in a single subject are shown. (*) Indicates positive responses, as defined in the Materials and Methods.
PBMC available from five T. cruzi-infected children were also stimulated with peptides encoded by the trans-sialidase gene family that bind alleles representative of the 6 most common class I HLA-supertypes, previously shown as targets of CD8+ T cell responses in chronically T. cruzi-infected adults . Strong IFN-γ ELISPOT responses specific for five out of the six supertype-binding trans-sialidase pooled peptides assessed were observed in one out of the five children (Figure 1B). In this same child, strong IL-2 responses to HLA-A3 and HLA-A24-binding peptides were also detected (Figure 1B). In opposition to T. cruzi-specific T cell responses, the magnitude of IFN-γ ELISPOT responses to irrelevant antigens, including class-I-restricted Flu peptides and tetanus toxoid, did not differ among uninfected children, uninfected adults and T. cruzi-infected adults (Figure 2), supporting the impairment of T cell responses is restricted to T. cruzi.
PBMC from uninfected children (n = 6), uninfected adults (n = 7) and long-term T.cruzi-infected adults (n = 10) were seeded at 4×105 cells/well and stimulated with class-I-restricted Flu-derived peptides (A), tetanus toxoid (B) or media alone for 16–20 h. Each symbol represents the mean spot number of triplicate wells for each patient with positive ELISPOT responses, as defined in material and methods. Spot counts with media alone were subtracted. Vertical lines depicting median values are shown. No significant differences were found among groups.
Cytokine/costimulation coexpression profiles in T. cruzi-infected children and adults
To further determine the quality of T. cruzi specific T cell responses earlier in infection, cytokine/co-stimulation co-expression profiles were assessed by intracellular staining following stimulation of whole blood with T. cruzi lysate. Since the T. cruzi lysate has proved to mainly induce CD4+ T cell responses and to a much lesser extent CD8+ T cell responses in chronic T. cruzi-infections , , we focused on CD4+ T cell responses for flow cytometry assays. The ability of CD4+ T cells to produce IFN-γ, TNF-α and CD154 (CD40L) - a marker of costimulatory potential - was evaluated in 19 T. cruzi-infected children. For comparison, this functional profile was also assessed in 10 T. cruzi-infected adults without evidence of cardiac involvement or with mild cardiac disease. Examining IFN-γ, TNF-α and CD154+ individually, CD154 was the most highly expressed in T. cruzi-infected children and there was a trend for higher proportions of cells expressing one or more of these three markers in the in the T. cruzi-infected children relative to the adults (Figure 3 and Figure S1). IFN-γ-producing CD4+ T cells was prevalent among T. cruzi-infected adults (Figure 3).
Whole blood was stimulated with an amastigote lysate preparation, and antigen-responsive CD4+ T cells were measured using an intracellular staining assay for IFN-γ, TNF-α and CD154. The percentage of total responsive CD4+ T cells for each individual function in nineteen T. cruzi-infected children (hatched columns) and ten adults with chronic T. cruzi infection (black columns) is plotted. Boxes and whiskers depicting median and 10th and 90th percentile values are shown. (*) P = 0.03 vs. CD4+TNF-α+ in T. cruzi-infected children and (&) P = 0.03 vs. CD4+TNF-α+ T cells in T. cruzi-infected adults by Kruskal-Wallis test with Dunn correction; (**) P = 0.004 vs. CD4+CD154+ in T. cruzi-infected adults and (≈) P = 0.006 vs. CD4+TNF-α+ T cells in T. cruzi-infected adults by Mann-Whitney U test.
A Boolean gating analysis was then performed to categorize cytokine/CD154 positive cells into seven different subsets consisting of triple, double or single cytokine/CD154-expressing populations. T. cruzi antigen responsive CD4+ T cells in children with positive serology for T. cruzi infection had representatives of all seven possible subsets (range 1–5 subsets per subject) (Figure 4A and 4C). CD4+ T cells responding to the lysate exert at least 2 functions in >90% of T. cruzi-infected children (Figure 4D). Polyfunctional cytokine-producing cells that simultaneously secrete IFN-γ and TNF-α dominated the CD4+ T cell responses in T. cruzi-infected children, followed by monofunctional and double expressing IFN-γ+CD154+ CD4+ T cells. TNF-α+CD154+ and triple expressing IFN-γ+TNF-α+CD154+ cells represented, in average, less than 20% of the total CD4+ T cell response to T. cruzi-antigens (Figure 4A and 4C). In contrast to children, CD4+ T cell responses in infected adults had representatives of only 3 out of the 7 possible subsets (Figure 4B and 4C), with a higher proportion of subjects displaying CD4+ T cells with single function than double function and none with all three functions (Figure 4D). In adult patients, monofunctional responses were dominated by IFN-γ-producing T cells followed by CD154+ T cells, whereas IFN-γ+CD154+ cells were predominant among the subsets with double function (Figure 4B).
PBMC were stimulated with a T. cruzi lysate preparation and cytokine/costimulation coexpression profiles with triple (ITD), double (IT, ID, TD) or single (I, T, D) function were determined in nineteen T. cruzi-infected children (A) and ten adults with chronic T. cruzi infection (B) using the Boolean gating function of FlowJo software. The proportions of CD4+ subsets positive for specific cytokines or co-stimulatory molecules were expressed as percentages of total cytokine/costimulatory-positive CD4+ T cells. Mean and SD are shown. (C) Summary of the functional composition of the CD4+ T cell response. Each slice of the pie represents the fraction of the total response that consists of CD4+ T cells positive for the different seven subsets. D) Prevalence of polyfunctional CD4+ T cell responses in T. cruzi-infected children (left panel) and adults (right panel). Each slice of the pie represents the percent of subjects with one (1+), two (2+) or three (3+) functions. I, IFN-γ; T, TNF-α; D, CD154. ITD, proportion of CD4+ T cells with concomitant expression of IFN-γ, TNF-α and CD154; IT, proportion of CD4+ T cells with concomitant expression of IFN-γ and TNF-α; ID, proportion of CD4+ T cells with concomitant expression of IFN-γ and CD154; TD, proportion of CD4+ T cells with concomitant expression of TNF-α and CD154; I, proportion of CD4+ T cells with IFN-γ only production; T, proportion of CD4+ T cells with TNF-α only production; D, proportion of CD4+ T cells with CD154 only expression.
Monofunctional CD154+ followed by monofunctional IFN+ T cells and double expressing IFN-γ+CD154+ T cells showed the highest magnitude of CD4+ T cell responses to T. cruzi antigens in T. cruzi-infected children (Figure S2A). Likewise, monofunctional T cells are also the main contributors to the total magnitude of CD4+ T cell responses to the lysate in T. cruzi-infected adults, but contrasting with children, T cell responses were enriched in single IFN-γ+ rather than single CD154+ T cells (Figure S2B).
CD4+ T cell phenotype in T. cruzi-infected children
We have previously reported that T. cruzi-infected children exhibit increased levels of terminally differentiated CD8+ T cells in the overall T cell compartment . In this study, the phenotype of total CD4+ T cells was evaluated for the expression of CD45RA, the co-stimulation molecules CD27 and CD28, the lymph node homing receptors CCR7 and CD62L, the IL-7 receptor CD127 and the co-inhibitory receptor killer-cell lectin like receptor G1 (KLRG-1), a marker of the number of TCR-triggering events , . Highly differentiated memory T cells (CD45RA−CD27−CD28− and CD45RA−CCR7−CD62L−) and terminally differentiated effector T cells (CD45RA+CCR−CD62L−) are increased in T. cruzi-infected children compared with uninfected controls (Table 3). The increased expression of HLA-DR indicates a high degree of activation of CD4+ T cells, while the increased expression of KLRG-1 along with a loss of the IL-7 receptor, suggests sustained antigen exposure of T cells in T. cruzi-infected children.
T cell deficiencies resulting from exhaustion include a hierarchical loss of effector functions along with the expression of inhibitory receptors, and failure to exhibit antigen-independent homeostatic proliferation , , . Although, this phenomenon was initially described for chronic viral infections, recent studies have shown that this process can also occur in protozoan diseases , . We have previously provided several pieces of evidence of immune exhaustion in adults with chronic T. cruzi-infection , –.
In this study, we report for the first time that T. cruzi-infected children in early stages of T. cruzi infection maintained polyfunctional CD4+ T cells responsive to T. cruzi antigens in their circulation. More than ninety percent of T. cruzi-infected children displayed responsive CD4+ T cells with double or triple functions. These findings are in sharp contrast to the profile observed in a group of adults with chronic T. cruzi-infections, in which most subjects showed monofunctional T. cruzi-specific responses enriched in single IFN-γ+ T cells with absence of TNF-α+-producing T cells. Other authors had also reported that children in the early phase of chronic T. cruzi infection exhibit IFN-γ+- and TNF-α+-secreting CD4+ T cells in response to T. cruzi antigens , .
The analysis of IFN-γ ELISPOT responses to the lysate and to trans-sialidase-derived class I peptides in T. cruzi-infected children also revealed that not only were the proportion with polyfunctional responses higher relative to infected adults, but that the magnitude of IFN-γ responses in these positive children was higher by 5-fold than previously reported in chronically T. cruzi-infected adults (i.e. median number of IFN-γ spots/4×105 PBMC in children = 220 vs. 52 spots evaluated in 150 subjects in the G0 group), [Laucella], [ unpublished data, 7,8]. Of note, the one single child responsive to trans-sialidase-derived CD8+ target peptides showed a stronger and broader response compared with our previous findings in adults (i.e. median number of IFN-γ spots/4×105 in this child = 87 spots, with five out of the six supertype-binding trans-sialidase pooled peptides recognized in average vs. 19 spots in 25 T. cruzi-infected adults, with two out of six pooled peptides recognized in average) . The differences are even more dramatic when comparing T. cruzi-infected children with adults exhibiting severe cardiomyopathy who mostly showed negative T cell responses against T. cruzi antigens , . Recent studies have also shown that individuals with severe cutaneous leishmaniasis have reduced CD8+ T cell numbers with the ability to produce IFN-γ and IL-2 .
Multifunctional T cells are optimized for effector function, exhibiting a higher secretion of IFN-γ on a per-cell basis, more efficient killing, and IL-2-mediated expansion of T cells in an autocrine or paracrine manner . In agreement with these findings, we observed a higher level of IFN-γ production in T. cruzi-infected children displaying both IFN+ and IL-2+ ELISPOT responses compared with those with single IFN-γ-producing T cells. It is likely that the maintenance of polyfunctional T cell responses provides more efficient control of T. cruzi infection and limits peripheral tissue damage. Indeed, most T. cruzi-infected children have not developed cardiac disease and previous studies from our group have shown higher frequencies of IFN-γ-producing T cells and higher magnitude of these responses in subjects with less severe forms of the disease compared with patients with severe cardiomypathy , , . Of note, seropositive children who were born and lived for some years in areas endemic for T. cruzi infection showed higher electrocardiographic abnormalities not related to Chagas disease compared to children born in non-endemic areas. This is likely due to co-morbidities and poorer socioeconomic conditions in rural areas. In this respect, we have shown that socioeconomic conditions had a significant influence on the progression of chronic Chagas disease which was independent of antiparasitic treatment and clinic characteristics . Nevertheless, the magnitude and quality of T. cruzi-specific T cell responses were not different between seropositive children born in endemic areas and those born in non-endemic areas, who are presumed to have been infected congenitally.
In T. cruzi infection, parasite persistence for decades, might drive a process of immune exhaustion. A broader range (relative to adults) of T. cruzi-specific immune phenotypes are present in T. cruzi-infected children – from “adult-like” monofunctional CD4+ T cell subsets to T cells exhibiting up to 3 functional properties. Thus, some T. cruzi-infected children display a T cell profile similar to that of adult patients. This is not unexpected since some children will likely have infections of >10 years. The increased frequencies of total effector/effector memory and activated CD4+ T cells in T. cruzi-infected children observed herein suggest a heightened state of immune activation as previously suggested in other studies , ,  In contrast to the unaltered levels of naïve CD4+ T cells shown herein, previous studies by our group in a similar patient population of children demonstrated a significant decrease in the levels of naïve CD8+ T cells compared to uninfected children . Likewise, Vitelli-Avelar reported decreased levels of CD62L+CD4+ T cells but lower frequencies of CD4+HLA-DR+ T cells along with unaltered levels of CD4+CD28+ T cells  in children in the indeterminate phase of the infection. Adults with chronic T. cruzi infection also show increased levels of activated, late differentiated memory and effector T cells, while naïve T cells are diminished as disease becomes more severe , , , . A crucial question remains whether the heterogeneity in the functional and phenotypic profile is a predictor of different disease outcome in these patients.
Children have not only shorter term infections but are also younger. Aging of the immune system in elderly subjects (generally older than 65 years of age), known as immunosenescence , is mainly associated to poor responsiveness to new pathogens and reduced efficacy of vaccination-induced protection against infection, while established memory immune responses to previously encountered pathogens are much less affected unless it is additionally stressed by chronic infections or autoimmune diseases , . Several studies have shown accelerated immune aging in HIV-infected subjects and subjects chronically infected with cytomegalovirus . In this study, chronically
T. cruzi-infected subjects are younger than 60 years, in average, and there were not differences in the magnitude of IFN-γ ELISPOT to irrelevant antigens like toxoid tetanus and Flu among uninfected children, uninfected adults T. cruzi-infected adults,. Of note, in previous studies, we did not found any association between the magnitude of T cell responses specific for T. cruzi and age in a cohort of chronically T. cruzi-infected subjects in an age range of between 22 and 70 years , . Furthermore, CD4+ T cells responsive to T. cruzi-antigens in T. cruzi-infected adults display high expression of the inhibitory receptor CTLA-4 which is a feature of exhausted T cells , while few T cells responsive to tetanus and diphtheria toxoids expressed CTLA-4 , supporting that impairment in T cell responses in T. cruzi-infected adults was confined to those specific for T. cruzi. The phenotype of the overall T cell compartment with an expansion of end-differentiated effector T cells and loss of naïve T cells in T. cruzi-infected children and adults compared with age-matched controls suggest that chronic T. cruzi infection might accelerate immune aging along with the induction of T cell exhaustion.
The quality of the immune response might also be a factor in the higher cure rates following drug treatment observed in children relative to adults . It had been proposed that IFN-γ production might promote the effectiveness of chemotherapy in patients with chronic T. cruzi infections , . All the children included in this study were treated with benznidazole, and are currently under follow-up. It will be of interest to address whether the response to therapy is associated with the qualitative and quantitative characteristics of the anti-T.cruzi T cell response prior to treatment.
T. cruzi –specific CD4+ T cell profile in children and adults with Chagas disease. Co-expression profiles of CD4+ T cells with the ability to produce IFN-γ, TNF-α, or to express the co-stimulatory molecule CD154 were measured by flow cytometry after 16–20 hs stimulation of whole blood with a T. cruzi lysate preparation. (A) Representative dot plots from one T. cruzi-infected child and one adult with chronic T. cruzi infection are shown. The numbers in the upper right quadrant indicate the percentage of CD4+IFN-γ+, CD4+TNF-α+ or CD4+ CD154+ T lymphocytes responsive to the lysate. (B) Representative dot blot of IFN-γ and TNF-α co-production by CD4+ T cells from the same patients showed in A. The numbers in the upper right quadrant indicate the percentage of CD4+IFN-γ+TNF-α+ T cells, while the numbers in the upper left represent the percentage of CD4+IFN-γ+TNF-α− T lymphocytes on total CD4+ T cells.
T. cruzi-specific CD4+ T cell responses in children and adults with Chagas disease. PBMC were stimulated with a T. cruzi lysate preparation and stained for IFN-γ, TNF-α and CD154. Triple, double or single functional profiles were determined by FlowJo Boolean gating analysis in nineteen T. cruzi-infected children (A) and ten T. cruzi-infected adults (B). Data are presented as the percentage of responding CD4+ T cells in each subset. Boxes depicting median and 5th and 95th percentile values are shown. I, IFN-γ; T, TNF-α; D, CD154. (**) P<0.01 vs. ITD and TD among T. cruzi-infected children; (&) P<0.05 vs. IT and T among T. cruzi-infected children; (*) P<0.05 vs. ITD, IT, TD and T among T. cruzi-infected adults, by the Kruskal-Wallis test with Dunn correction.
We thank the staff and patients of the “Instituto Nacional de Parasitología Dr. Mario Fatala Chaben” and the “Hospital Interzonal General de Agudos Eva Perón” who provided blood samples, and Laura Mansilla and Daniela Oliveto for technical assistance.
Conceived and designed the experiments: SAL MCA RLT. Performed the experiments: MCA SAL MGA AMDR AA DP GT AS MIE LEF. Analyzed the data: MCA SAL MGA RV. Contributed reagents/materials/analysis tools: SAL RLT. Wrote the paper: SAL RLT MCA.
- 1. World Health Organization (2012) Research Priorities for Chagas disease, Human African Trypanosomiasis and Leishmaniasis. Tech Rep Ser 1–100.
- 2. Schmunis GA, Yadon ZE (2010) Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop 115: 14–21. doi: 10.1016/j.actatropica.2009.11.003
- 3. Tarleton RL (2003) Chagas disease: a role for autoimmunity? Trends Parasitol 19: 447–451. doi: 10.1016/j.pt.2003.08.008
- 4. Dutra WO, Gollob KJ (2008) Current concepts in immunoregulation and pathology of human Chagas disease. Curr Opin Infect Dis 21: 287–292. doi: 10.1097/qco.0b013e3282f88b80
- 5. Virgin HW, Wherry EJ, Ahmed R (2009) Redefining chronic viral infection. Cell 138: 30–50. doi: 10.1016/j.cell.2009.06.036
- 6. Gigley JP, Bhadra R, Moretto MM, Khan IA (2012) T cell exhaustion in protozoan disease. Trends Parasitol 28: 377–384. doi: 10.1016/j.pt.2012.07.001
- 7. Alvarez MG, Postan M, Weatherly DB, Albareda MC, Sidney J, et al. (2008) HLA class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease. PLoS Negl Trop Dis 2: e288. doi: 10.1371/journal.pntd.0000288
- 8. Laucella SA, Postan M, Martin D, Hubby Fralish B, Albareda MC, et al. (2004) Frequency of interferon-g-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J Infect Dis 189: 909–918. doi: 10.1086/381682
- 9. Albareda MC, Olivera GC, De Rissio AM, Postan M (2010) Short Report: Assessment of CD8 + T Cell Differentiation in Trypanosoma cruzi -Infected Children. Am J Trop Med Hyg 82: 861–864. doi: 10.4269/ajtmh.2010.09-0604
- 10. Samudio M, Montenegro-James S, Cabral M, Martinez J, Rojas de Arias A, James MA (1998) Cytokine responses in Trypanosoma cruzi-infected children in Paraguay. Am J Trop Med Hyg 58: 119–121.
- 11. Sathler-Avelar R, Vitelli-Avelar DM, Massara RL, Borges JD, Lana M, et al. (2006) Benznidazole Treatment during Early-indeterminate Chagas' Disease Shifted the Cytokine Expression by Innate and Adaptive Immunity Cells toward a Type 1-modulated Immune Profile. Scand J Immunol 64: 554–563. doi: 10.1111/j.1365-3083.2006.01843.x
- 12. World Health Organization (2002) Control of Chagas disease. Second Report of the WHO Expert Committee 905: 1–109.
- 13. Kuschnir E, Sgammini H, Castro R, Evequoz C, Ledesma R, et al. (1985) Valoración de la función cardíaca por angiografía radioisotópica, en pacientes con cardiopatía chagásica crónica. Arq Bras Cardiol 45: 249–256.
- 14. Bertocchi GL, Vigliano CA, Lococo BG, Petti MA, Viotti RJ (2013) Clinical characteristics and outcome of 107 adult patients with chronic Chagas disease and parasitological cure criteria. Trans R Soc Trop Med Hyg 107: 372–376. doi: 10.1093/trstmh/trt029
- 15. Laucella SA, Mazliah DP, Bertocchi G, Alvarez MG, Cooley G, et al. (2009) Changes in Trypanosoma cruzi-specific immune responses after treatment: surrogate markers of treatment efficacy. Clin Infect Dis 49: 1675–1684. doi: 10.1086/648072
- 16. Day CL, Abrahams DA, Lerumo L, Janse van Rensburg E, Stone L, et al. (2011) Functional Capacity of Mycobacterium tuberculosis-Specific T Cell Responses in Humans Is Associated with Mycobacterial Load. J Immunol 187: 2222–2232. doi: 10.4049/jimmunol.1101122
- 17. Yellin MJ, Sippel K, Inghirami G, Covey LR, Lee JJ, et al. (1994) CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. Potential role in regulating helper effector function. J Immunol 152: 598–608.
- 18. Frentsch M, Arbach O, Kirchhoff D, Moewes B, Worm M, et al. (2005) Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat Med 11: 1118–1124. doi: 10.1038/nm1292
- 19. Barrett PA, Peter CT, Swan HJC, Singh BN, Mandel WJ (1981) The frequency and prognostic significance of electrocardiographic abnormalities in clinically normal individuals. Prog Cardiovasc Dis 23: 299–319. doi: 10.1016/0033-0620(81)90018-9
- 20. Olivera GC, Albareda MC, Alvarez MG, De Rissio AM, Fichera LE, et al. (2010) Trypanosoma cruzi-specific immune responses in subjects from endemic areas of Chagas disease of Argentina. Microbes Infect 12: 359–35. doi: 10.1016/j.micinf.2010.01.011
- 21. Henson SM, Franzese O, Macaulay R, Libri V, Azevedo RI, et al. (2009) KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells. Blood 113: 6619–6628. doi: 10.1182/blood-2009-01-199588
- 22. Joshi NS, Kaech SM (2008) Effector CD8 T cell development: a balancing act between memory cell potential and terminal differentiation. J Immunol 180: 1309–1315.
- 23. Vigano S, Perreau M, Pantaleo G, Harari A (2012) Positive and Negative Regulation of Cellular Immune Responses in Physiologic Conditions and Diseases. Clin Dev Immunol 2012: 485781. doi: 10.1155/2012/485781
- 24. Odorizzi PM, Wherry EJ (2012) Inhibitory receptors on lymphocytes: insights from infections. J Immunol 188: 2957–2965. doi: 10.4049/jimmunol.1100038
- 25. Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, et al. (2007) Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13: 843–850. doi: 10.1038/nm1592
- 26. Albareda MC, Laucella SA, Alvarez MG, Armenti AH, Bertochi G, et al. (2006) Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients. Int Immunol 18: 465–471. doi: 10.1093/intimm/dxh387
- 27. Albareda MC, Olivera GC, Laucella SA, Alvarez MG, Fernandez ER, et al. (2009) Chronic human infection with Trypanosoma cruzi drives CD4+ T cells to immune senescence. J Immunol 183: 4103–4108. doi: 10.4049/jimmunol.0900852
- 28. Perez-Mazliah DE, Alvarez MG, Cooley G, Lococo BE, Bertocchi G, et al. (2013) Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study. J Antimicrob Chemother 68: 424–437. doi: 10.1093/jac/dks390
- 29. Arguello RJ, Albareda MC, Alvarez MG, Bertocchi G, Armenti AH, et al. (2012) Inhibitory Receptors Are Expressed by Trypanosoma cruzi-Specific Effector T Cells and in Hearts of Subjects with Chronic Chagas Disease. PLOS One 7: e35966. doi: 10.1371/journal.pone.0035966
- 30. Hernández-Ruiz J, Salaiza-Suazo N, Carrada G, Escoto S, Ruiz-Remigio A, et al. (2010) CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists. PLoS Negl Trop Dis 4: e871. doi: 10.1371/journal.pntd.0000871
- 31. Seder RA, Darrah PA, Roederer M (2008) T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 8: 247–258. doi: 10.1038/nri2274
- 32. Viotti R, Vigliano CA, Alvarez MG, Lococo BE, Petti MA, et al. (2009) The impact of socioeconomic conditions on chronic Chagas disease progression. Rev Esp Cardiol 62: 1224–1232. doi: 10.1016/s1885-5857(09)73349-3
- 33. Laucella SA, Segura EL, Riarte A, Sosa ES (1999) Soluble platelet selectin (sP-selectin) and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease during therapy with benznidazole in children with indeterminate form of Chagas' disease. Clin Exp Immunol 118: 423–427. doi: 10.1046/j.1365-2249.1999.01070.x
- 34. Cutrullis RA, Moscatelli GF, Moroni S, Volta BJ, Cardoni RL, et al. (2011) Benzonidazole therapy modulates interferon-γ and M2 muscarinic receptor autoantibody responses in Trypanosoma cruzi-infected children. PLoS One 6: e27133. doi: 10.1371/journal.pone.0027133
- 35. Vitelli-Avelar DM, Sathler-Avelar R, Massara RL, Borges JD, Lage PS, et al. (2006) Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25highT cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity? Clin Exp Immunol 145: 81–92. doi: 10.1111/j.1365-2249.2006.03123.x
- 36. Fiuza JA, Fujiwara RT, Gomes JA, Rocha MO, Chaves, et al (2009) Profile of Central and Effector Memory T Cells in the Progression of Chronic Human Chagas Disease. Plos Negl Tropical Dis 3: e512. doi: 10.1371/journal.pntd.0000512
- 37. Akbar AN, Henson SM (2011) Are senescence and exhaustion intertwined or unrelated processes that compromise immunity? Nat Rev Immunol 11: 289–295. doi: 10.1038/nri2959
- 38. Nikolich-Zugich J (2008) Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat Rev Immunol 7: 512–522. doi: 10.1038/nri2318
- 39. Le Saux S, Weyand CM, Goronzy JJ (2012) Mechanisms of immunosenescence: lessons from models of accelerated immune aging. Ann N Y Acad Sci 1247: 69–82. doi: 10.1111/j.1749-6632.2011.06297.x
- 40. Sauce D, Larsen M, Fastenackels S, Duperrier A, Keller M, et al. (2009) Evidence of premature immune aging in patients thymectomized during early childhood. J Clin Invest 119: 3070–3078. doi: 10.1172/jci39269
- 41. Kaufmann DE, Kavanagh DG, Pereyra F, Zaunders JJ, Mackey EW, et al. (2007) Upregulation of CTLA-4 by HIV-specific CD4 T cells correlates with disease progression and defines a reversible immune dysfunction. Nat Immunol 8: 1246–1254. doi: 10.1038/ni1515
- 42. Sosa-Estani S, Viotti R, Segura EL (2009) Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina. Mem Inst Oswaldo Cruz 104: 167–180. doi: 10.1590/s0074-02762009000900023
- 43. Bahia-Oliveira LMG, Gomes JAS, Cancado JR, Ferrari TC, Lemos EM, et al. (2000) Immunological and clinical evaluation of chagasic patients subjected to chemotherapy during the acute phase of Trypanosoma cruzi infection 14–30 years ago. J Infect Dis 182: 634–638. doi: 10.1086/315743